TrialPloS one2020

Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6.

Heleen H DeCory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.